Skip to content

Risk assessment of COVID-19 vaccine in patients with epilepsy: a multicenter retrospective observational study

Risk assessment of COVID-19 vaccine in patients with epilepsy: a multicenter retrospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048925
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-05-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

case series:Nil

Sponsors

Shandong University Qilu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 82 Years

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with epilepsy according to the criteria proposed by the International Anti-Epilepsy Union in 2017; 2) Aged 18 to 65 years; 3) Completed Novel Coronavirus vaccine vaccination; 4) Patients and their family members gave informed consent to participate in this study voluntarily.

Exclusion criteria

Exclusion criteria: 1. The patient or the guardian of the patient refused to sign the informed consent. 2. The injection of COVID-19 vaccine was not carried out as required; 3. Unable to complete the questionnaire and follow-up follow-up; 4. Unable to provide accurate epileptic history (including before and after vaccination); 5. Patients were lost during follow-up or voluntarily withdrew from the study.

Design outcomes

Primary

MeasureTime frame
number of seizures after vaccination;

Secondary

MeasureTime frame
Adverse reactions;Result of EEG;

Countries

China

Contacts

Public ContactXue-wu Liu

Shandong University Qilu Hospital

snlxw1966@163.com+86 18560085520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026